GoHealth

GOCO

Market cap $70M

As millions of Medicare beneficiaries face significant plan disruption for 2026, GoHealth aims to deliver peace of mind As millions of Medicare beneficiaries face significant plan disruption for 2026, GoHealth aims to deliver peace of mind

GoHealth, Inc. (NASDAQ:GOCO ) Q2 2025 Earnings Conference Call August 7, 2025 8:00 AM ET Company Participants John E. Shave - Vice President of Investor Relations Vijay Kumar Kotte - CEO & Director Conference Call Participants David Joseph Storms - Stonegate Capital Partners, Inc., Research Division Ilya Zubkov - Freedom Broker, Research Division James Philip Sidoti - Sidoti & Company, LLC Patrick Joseph McCann - NOBLE Capital Markets, Inc., Research Division Robert Miles McGuire - Granite Research, LLC Operator Good day, and welcome to the GoHealth Second Quarter 2025 Earnings Conference Call.

Dallas, Texas--(Newsfile Corp. - August 8, 2025) - GoHealth Inc. (NASDAQ: GOCO): Stonegate Capital Partners updates their coverage on GoHealth Inc. (NASDAQ: GOCO). GoHealth, Inc. delivered a challenged second quarter in 2025, highlighted by revenue declines and contracting margins.

GoHealth (GOCO) came out with a quarterly loss of $1.23 per share versus the Zacks Consensus Estimate of a loss of $2.6. This compares to a loss of $0.75 per share a year ago.

CHICAGO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc.  (GoHealth) (NASDAQ: GOCO), a leading health insurance marketplace and Medicare-focused digital health company, will announce strategic capital and governance actions to support long-term value creation and its second quarter 2025 financial results on the morning of August 7, 2025.

NEW YORK, July 13, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GoHealth, Inc. (NASDAQ: GOCO) resulting from allegations that GoHealth may have issued materially misleading business information to the investing public.

NEW YORK , July 11, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GoHealth, Inc. (NASDAQ: GOCO) resulting from allegations that GoHealth may have issued materially misleading business information to the investing public. So What: If you purchased GoHealth securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GoHealth, Inc. (NASDAQ: GOCO) resulting from allegations that GoHealth may have issued materially misleading business information to the investing public.

NEW YORK , July 3, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GoHealth, Inc. (NASDAQ: GOCO) resulting from allegations that GoHealth may have issued materially misleading business information to the investing public. So What: If you purchased GoHealth securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GoHealth, Inc. (NASDAQ: GOCO) resulting from allegations that GoHealth may have issued materially misleading business information to the investing public.